Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

NK cells play a role in skin diseases like eczema and psoriasis.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Effective treatments for severe alopecia areata are still lacking.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Possible link between androgens and COVID-19 severity; more research needed.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.